奥格门丁(Augmentin)是棒酸(Clavulanic acid)与羟氨苄青霉素(Amoxicillin)的复方制剂,内含羟氨苄青霉素1.0g,棒酸0.2g。本组所用奥格门丁静脉注射针剂为英国比切姆公司原粉,由华北制药厂生产提供。本组试验共治疗细菌性感染42例。其中16例试验药奥格门丁与对照药头孢拉定(Cephradine)16例进行随机对照临床试验,两组临床痊愈显效率分别为87.5%与81.3%,细菌消除率分别为83.3%与81.3%;奥格门丁共观察26例(开放10例,随机对照16例),临床痊愈显效率为88.5%,细菌消除率为85.7%,不良反应发生率15.38%。 Augmentin is a compound preparation of clavulanic acid and amoxicillin, containing 1.0 g of amoxicillin and 0.2 g of clavulanic acid. The group used Ogmeintin intravenous injection injection for the British company than the original Bechem, manufactured by the North China Pharmaceutical Factory. This group of tests were treated 42 cases of bacterial infection. Among them, 16 cases of testosterone and control cephradine (16 cases) were randomized controlled clinical trials. The clinical effective rates of two groups were 87.5% and 81.3% respectively, and the elimination rates were 83.3% and 81.3% respectively. Gemcandine observed a total of 26 cases (open 10 cases, 16 cases of randomized controlled clinical curative effect was 88.5%, bacterial elimination rate was 85.7%, the incidence of adverse reactions was 15.38%.